Ticker LaunchReverse merger · Completed · CALC
CalciMedica, Inc.
Reverse merger with Graybug Vision, Inc. (GRAY)
CalciMedica, Inc. merged into Graybug Vision, Inc. (GRAY), a Nasdaq-listed clinical-stage biotech, in a reverse merger that takes the private company public. The deal was announced on Nov 22, 2022 and closed on Mar 22, 2023. The combined company trades as CalciMedica, Inc. (CALC) on Nasdaq.
CalciMedica is a clinical-stage biopharmaceutical company developing Auxora, a CRAC channel inhibitor in Phase 2b for acute pancreatitis, plus other first-in-class candidates for life-threatening inflammatory diseases. It became public by merging with Graybug Vision.
- Status
- Completed
- Private company
- CalciMedica, Inc.
- Public company
- Graybug Vision, Inc. (GRAY)
- Public company business before
- Nasdaq-listed clinical-stage biotech
- Announced
- Nov 22, 2022
- Closed
- Mar 22, 2023
- Combined company
- CalciMedica, Inc. (CALC)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
Other completed reverse mergers
- Zircon Corporationinto Harmony Energy Technologies Corporation · Apr 13, 2023
- Charging Robotics Ltd.into Fuel Doctor Holdings, Inc. · Apr 7, 2023
- Megamile Capital, Inc. (Mag Mile Capital)into Myson, Inc. · Mar 30, 2023
- Sannong Youxuan (BVI) Limitedinto Huaizhong Health Group, Inc. · Mar 27, 2023
- Best Labs, Inc.into Nowtransit Inc · Mar 10, 2023
- Carisma Therapeutics Inc.into Sesen Bio, Inc. · Mar 7, 2023